Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 233.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.431%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 233.00
DATA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update & Announcement of Investor Seminar

11 Jan 2024 07:00

RNS Number : 3183Z
GlobalData PLC
11 January 2024
 

11 January 2024

 

GlobalData Plc

(AIM: DATA, "GlobalData", the "Group")

 

Full year trading update and announcement of Investor Seminar

 

GlobalData Plc, a leading data, analytics, and insights platform, today provides the following update on trading following the end of its financial year to 31 December 2023 ("FY2023").

 

Following its interim results on 31 July 2023, GlobalData continued to deliver strong profitable growth throughout the second half. For FY2023, the Group expects to deliver Group revenue of c.£273m (2022: £243m), reflecting annual growth of 12% (7% underlying), and adjusted EBITDA growth of 28% to c.£111m (2022: £86m), which is within range of market expectations for the year. EBITDA margin was strong at c.41% (2022: 36%).

 

On 21 December 2023, we announced the launch of our new growth plan and Group reorganisation to operate across three customer-focused divisions - Healthcare, Consumer, and Technology - and also the transaction to sell a minority stake in our Healthcare business, which accounted for c.36% of revenue, at a valuation of £1,115m, raising net cash proceeds of approximately £434m.The transaction, which will provide flexibility for accelerated value-creating M&A across the Group, is progressing in line with our expectations and we expect to complete in Q2 2024.

 

GlobalData will host an investor and analyst seminar to focus on the new growth strategy and the customer-focused divisions, as well as further information on the impact of the Healthcare transaction on 24 January 2024 at 2pm. Please register your interest to attend this event with globaldata@fticonsulting.com.

 

FY2023 results, in full, will be announced on 4 March 2024.

 

Mike Danson, Chief Executive Officer of GlobalData Plc, commented:

 

"Over the last year, GlobalData has continued to execute on its growth optimisation plan and provide its global customer base with mission-critical insights and analysis. The result of this is we exited 2023 with another period of strong profitable growth and an EBITDA margin of more than 40%.

 

As we look ahead, we enter 2024 with a new growth plan and operating structure, which when added to our strong financial position, allows GlobalData to pursue a more ambitious growth strategy across the three divisions and create substantial value over the medium term."

 

 

ENDS

 

 

ENQUIRIES

 

GlobalData Plc

Mike Danson, Chief Executive Officer

0207 936 6400

Graham Lilley, Chief Financial Officer

J.P. Morgan Cazenove (Nomad, Joint Broker)

0203 493 8000

Bill Hutchings

Mose Adigun

Panmure Gordon (Joint Broker)

0207 886 2500

Rupert Dearden

Dougie McLeod

Deutsche Numis Securities (Joint Broker)

Nick Westlake

Iqra Amin

 

0207 260 1000

FTI Consulting (Financial PR)

0203 727 1000

Edward Bridges

Dwight Burden

Emma Hall

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFAESSELSEDF
Date   Source Headline
1st Mar 20167:00 amRNSFinal Results
26th Jan 201611:02 amRNSHoldings in Company and Director Shareholding
25th Jan 20168:00 amRNSCompletion of Acquisition and Disposal
19th Jan 20161:31 pmRNSResult of General Meeting
23rd Dec 20157:00 amRNSAcquisition and Disposal
18th Dec 20157:00 amRNSPossible Acquisition and Disposal
1st Sep 20157:03 amRNSCompletion of Acquisition
27th Jul 20157:01 amRNSInterim Results
27th Jul 20157:00 amRNSAcquisition of Business Assets from Informa plc
21st Apr 201512:52 pmRNSResult of Annual General Meeting
27th Mar 20157:00 amRNSAnnual Report and Accounts and Notice of AGM
2nd Mar 20157:00 amRNSFinal Results
4th Dec 20147:00 amRNSPre-Close Trading Update
7th Oct 20142:36 pmRNSHolding(s) in Company
5th Aug 20143:02 pmRNSNotification of Major Interests in Shares
30th Jul 20145:06 pmRNSAcquisition Completion
28th Jul 20147:00 amRNSInterim Results
17th Jul 20141:39 pmRNSNew Banking Facilities
8th Jul 20147:00 amRNSAcquisition of CurrentAnalysis Inc.
23rd Apr 20147:34 amRNSResult of AGM
31st Mar 20147:00 amRNSIssue of Equity
14th Mar 20147:00 amRNSIssue of Equity
7th Mar 201412:21 pmRNSIssue of Equity and Director's Dealings
24th Feb 20147:00 amRNSPreliminary Results
2nd Jan 20147:00 amRNSAcquisition
10th Dec 20137:00 amRNSAcquisition
29th Jul 20137:00 amRNSInterim Results
24th May 20139:05 amRNSCapital Reduction
22nd May 201311:18 amRNSCapital Reduction
24th Apr 20131:09 pmRNSResult of AGM and GM
12th Apr 20137:00 amRNSAdditional listing
26th Mar 20137:00 amRNSProposed Capital Reduction and Consolidation
25th Feb 20137:00 amRNSPreliminary Results
12th Nov 20127:00 amRNSAdviser Change of Name
26th Jul 20127:00 amRNSInterim Statement
5th Jul 20127:00 amRNSTrading Update
30th Apr 20127:00 amRNSDirectors' Dealings
27th Apr 201210:53 amRNSResult of AGM and EGM
5th Apr 20127:00 amRNSProposed Placing
2nd Apr 20122:46 pmRNSAnnual report and accounts and Notice of AGM
22nd Mar 201212:57 pmRNSDirector/PDMR Shareholding
6th Mar 20127:09 amRNSFinal Results
5th Mar 20127:00 amRNSChange of Adviser
27th Sep 201111:33 amRNSDirector/PDMR Shareholding
1st Aug 20117:00 amRNSInterim Results
6th Jul 20117:00 amRNSBoard Appointments
28th Apr 20114:18 pmRNSResult of AGM
31st Mar 20117:00 amRNSAnnual report and accounts and Notice of AGM
3rd Mar 20117:00 amRNSPreliminary Results
9th Dec 20104:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.